DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

CT Homepage

Spectral CT, workflow and dose reduction drive new CT scanner and software releases

Purchasing insight: Navigating the CT market Important considerations when it's time to shop around

IMRIS and Siemens take on growing hybrid OR neurosurgical market together Support sales for MR, CT and angiography

Stryker inks two partnerships for enhanced surgical guidance Offering whole-brain tractography and detail-rich imaging

Could proposed EPA rule change lead to less stringent radiation exposure regulations? Experts warn looser guidelines could harm patients and providers

The present and future of spectral imaging Insights from Christian Eusemann, Ph.D., vice president of collaborations at Siemens Healthineers North America

Low-dose, mobile CT technology powers the future of lung care Recounting benefits it has brought to the Levine Cancer Institute

Congress to evaluate bill on CT colonography coverage Would expand coverage of CT colonography for colorectal cancer

NIH grants over $1 million to development of non-contrast imaging approaches Will be used to diagnose peripheral arterial disease

China's Infervision brings AI tech to 200th hospital Now in use with approx. 20,000 lung cancer screening scans daily

US lawmakers seek exemption for medical devices under China tariffs

by John R. Fischer , Staff Reporter
U.S. Congress members Scott Peters (D-CA) and Erik Paulsen (R-MN) are calling on the U.S. Office of the United States Trade Representative to remove all Chinese-imported medical devices, including imaging equipment, from the list of imports subject to Section 301 tariffs.

With the support of 40 lawmakers, the two urged United States Trade Representative Robert Lightizer in a bipartisan letter to reconsider including almost $3 billion worth of medical equipment under the tax, out of fear that doing so could hurt U.S. manufacturers’ ability to compete globally, and would raise healthcare costs, thereby depriving patients access to lifesaving technologies.

Story Continues Below Advertisement

Dunlee announces the relaunch of DA135 CT/e, DA165NP and Akron tubes

Dunlee announces the return of the DA135 CT/e, DA165NP, S532B and S532Q(known as the Akron tubes) CT Replacement tubes, making its full portfolio of CT tubes for GE and Siemens CT scanners available once again.Click to learn more



“With its growing economy and middle class, rapidly aging population, and increased demand for medical technology, China will continue to be an attractive market for U.S. manufacturers,” the lawmakers said in the letter. “With that in mind, we are concerned that inclusion of medical devices on any final Section 301 tariff list could lead to retaliation that would jeopardize these opportunities.”

Announced in March by President Donald J. Trump, the proposal aims to curb interest among American companies in transferring technology and intellectual property to domestic Chinese enterprises, issuing a 25 percent tariff on $50 billion worth of goods imported from China.

The USTR argues that such an action is valid under Section 301 of the Trade Act of 1974, which authorizes the president to take all appropriate measures, including retaliation, to remove any act, policy, or practice of a foreign government that violates an international trade agreement or is considered unjustified, unreasonable, or discriminatory, and that burdens or restricts U.S. commerce.

In the letter, lawmakers reference the U.S. medical technology industry as “an American success story” and “one of the few with a consistent trade surplus,” claiming that such achievements could be hindered by a possible retaliation by China to the tax.

The form of this response could include the East Asian country’s own tariffs on U.S. medical technology products or non-tariff barriers that could delay or prevent market access, hurting the ability of U.S. manufactures to compete globally.

They also point to the fact that imports for the $25 billion Chinese market are expected to grow. The implementation of the tariffs, they argue, ignores the nearly balanced trading relationship between the two regarding medical technology products, and could cause China to retaliate by placing its own tariffs on U.S. medical technology products or non-tariff barriers that could delay or prevent market access. Such actions could prevent them from competing on a global scale.
  Pages: 1 - 2 >>

CT Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED